GenMark Diagnostics, Inc. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017	FY2016 12 months to Dec 31, 2016
Product revenue
Revenue
Product revenue
Other revenue
Total revenue
Cost of revenue
Gross profit
Operating expenses
Sales and marketing
General and administrative
Research and development
Total operating expenses
Operating loss
Other income (expense)
Interest income
Interest expense
Other income (expense)
Total other expense
Loss before income taxes
Income tax expense
Net loss
AOCI Attributable to Parent
Total net loss
Net loss per share—basic and diluted
Weighted average number of shares outstanding—basic and diluted
Other comprehensive income
Foreign currency translation adjustments, net of tax
AOCI Attributable to Parent
Total foreign currency translation adjustments, net of tax
Net unrealized gain on marketable securities, net of tax
AOCI Attributable to Parent
Total net unrealized gain on marketable securities, net of tax
Total other comprehensive income
Total comprehensive loss

Comments